feed,title,long_url,short_url
Benzinga,Investors Cheer Positive Data From KalVista's KVD900 Mid-Stage Hereditary Angioedema Trial,https://www.benzinga.com/general/biotech/21/02/19564883/investors-cheer-positive-data-from-kalvistas-kvd900-mid-stage-hereditary-angioedema-trial,https://j.mp/3a1Caz4
